Article
Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies
7 Apr 2017
Abstract excerpt
Dendritic cells (DCs) are specialized APCs present in all tissues, including tumors. They play a major role in orchestrating immune responses and were shown to occur in various functional states in tumors. In this respect, immunogenic tumor-associated DCs (TADCs) are required to initiate and sustain T cell-dependent anti-cancer immunity, whereas regulatory TADCs harbor robust immunosuppressive potential and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
